Investor Presentaiton slide image

Investor Presentaiton

$30.1M REPORTED EBITDA +$4.6M +18% vs PCP $12.8M REPORTED NPAT +35% vs PCP $209M 60.3% DELIVERING ON OUR Plan (NUMBERS) 18.2EPS • HEADLINES • Reported EBITDA $30.1M +18% vs PCP, at top end of guidance Second highest earnings of all time in the history of Comvita EPS +34% vs PCP • $12.8M NPAT +35% vs PCP • Record revenue $209M +9% +$17M vs PCP . Record gross profit $126M +22% vs PCP, on track with 2025 plan $28.1M MARKETING RECORD REVENUE GROSS PROFIT • INVESTMENT +16% +9.0% +640 BPS COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY22 • Double digit bottom-line growth: • North America • China • Mānuka honey • Ecommerce $28.1M investment in our brand enabling us to tell our founding story to consumers around the world • Gaining market share in key markets 8
View entire presentation